ADLM Names New CEO
The association's incoming CEO brings more than two decades of leadership experience in global health, nonprofit management, and the scientific community.
The association's incoming CEO brings more than two decades of leadership experience in global health, nonprofit management, and the scientific community.
The system combines enhanced sensitivity with automation to detect M-proteins at low concentrations, supporting early diagnosis of plasma cell disorders.
Studies demonstrate artificial intelligence achieving 93% cancer diagnostic accuracy and enabling noninvasive tumor analysis through spinal fluid testing.
E Tech Group's Sura Hadi will facilitate discussion on practical implementation and maturity levels of digital twin technology in laboratory design.
The multiplex PCR assay achieved 100% accuracy while reducing turnaround time for histoplasmosis, blastomycosis, and coccidioidomycosis diagnosis.